Remyelination in humans due to a retinoid‐X receptor agonist is age‐dependent
Open Access
- 19 May 2022
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 9 (7) , 1090-1094
Abstract
Remyelination efficiency declines with advancing age in animal models, but this has been harder to demonstrate in people with multiple sclerosis. We show that bexarotene, a putatively remyelinating retinoid‐X receptor agonist, shortened the visual evoked potential latency in patients with chronic optic neuropathy aged under 42 years only (with the effect diminishing by 0.45 ms per year of age); and increased the magnetization transfer ratio of deep gray matter lesions in those under 43 years only. Addressing this age‐related decline in human remyelination capacity will be an important step in the development of remyelinating therapies that work across the lifespan.Keywords
This publication has 16 references indexed in Scilit:
- Predictors of response to opicinumab in acute optic neuritisAnnals of Clinical and Translational Neurology, 2018
- Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialThe Lancet, 2017
- Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelinationBrain, 2015
- Cortical remyelination: A new target for repair therapies in multiple sclerosisAnnals of Neurology, 2012
- Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosisMultiple Sclerosis Journal, 2012
- Rejuvenation of Regeneration in the Aging Central Nervous SystemCell Stem Cell, 2012
- Retinoid X receptor gamma signaling accelerates CNS remyelinationNature Neuroscience, 2010
- The rising prevalence and changing age distribution of multiple sclerosis in ManitobaNeurology, 2010
- Age at onset determines the occurrence of the progressive phase of multiple sclerosisNeurology, 2007
- Age at disability milestones in multiple sclerosisBrain, 2006